Omega-3 and -6 Fatty Acids - 1. Baseline and monitoring of individuals with known CVD (acute and chronic) to deterimine Rx and compliance. 2. Identify patients with known CVD risk with low omega-3 levels who may be candidates for supplementation/therapy. 3. Monitor patients on omega-3 supplementation/therapy to determine efficacy of treatment. 4. Potential role in risk reduction for non-CVD outcomes-aged related macular degeneration, RA, cancer, etc. (early data).
Nutrients, Heart Disease
- Eicosapentaenoic acid (EPA)
- Docosahexaenoic acid (DHA)
- Arachidonic acid (AA)
Calculated omega-3 Index, omega-3/omega-6 ratio, and AA/EPA ratio.